Celecoxib shows potential benefit for Duchenne muscular dystrophy
Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy...
List view / Grid view
News
Federal judge enters consent decree against outsourcing facility
U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction between the United States and Isomeric Pharmacy Solutions...
AI algorithm detects retinopathy of prematurity
New algorithm could help overcome shortage of physicians trained in disease diagnosis...
Zoledronic acid could be used to treat basal-like breast cancer
Researchers have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer...
Artificial retina may restore sight
A simple retinal prosthesis is being developed in hope that it can restore sight to blind people...
Use of NSAIDs reduces progression-free survival of patients with mRCC
Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
MAT-blood test safely and accurately diagnoses peanut allergies
Scientists have developed a new test to diagnose peanut allergy that doesn't run the risk of false-positives or causing allergic reactions...
Organ-chips model and predict thrombotic side effect caused by anti-CD154 antibody hu5c8
An Emulate, Inc. study has demonstrated that its Blood Vessel-Chip accurately modelled and predicted thrombosis, or clotting of blood, induced by certain monoclonal antibody drugs, specifically anti-CD154 monoclonal antibody (mAb) hu5c8.
Lapatinib can accelerate cancer cell growth
The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab...
Wickham Laboratories to present at Cleanroom Technology Conference 2018
Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16 May at 2:30PM, at the National Conference Centre in Birmingham...
New UV-1900 UV-Vis Spectrophotometer
Industry's fastest level scan function and LabSolutions UV-Vis control software...
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Pill for breast cancer diagnosis may outperform mammograms
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
FDA approves Tafinlar/Mekinist for BRAF V600-mutant melanoma
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
FDA grants orphan drug designation to elamipretide for LHON
The FDA granted Orphan Drug Designation to elamipretide, for the treatment of Leber's hereditary optic neuropathy...
